Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > generic: None

& classes

: Empathogen

or Selective norepinephrine reuptake inhibitor (NRI) with 5HT1A partial agonism

Use the filters below to narrow your results.

Qelbree (1)

Selective NET inhibitor (no significant DAT activity, distinguishes from amphetamine/methylphenidate). Also: 5HT1A receptor partial agonism, 5HT2B and 5HT7 receptor antagonism. The serotonergic actions may underlie better tolerability and possibly different efficacy spectrum than atomoxetine. (1)

ADHD in children (6+), adolescents, and adults (FDA-approved 2021 for pediatric, 2022 for adult) (1)

Pediatric 6-11: 100 mg PO daily, titrate weekly to max 400 mg. Adolescent 12-17: 200 mg, max 400 mg. Adult: 200 mg, max 600 mg. (1)

100 mg, 150 mg, 200 mg extended-release capsules (can be sprinkled on food) (1)

400 mg/d (pediatric); 600 mg/d (adult) (1)

Oral (1)

ADHD symptom improvement reported within 1-2 weeks (faster than atomoxetine which takes 4-6 weeks) (1)

Daily dosing (1)

~7 hours (1)

Adequate oral bioavailability with extended-release formulation (1)

Limited data (1)

Rx, '''not a controlled substance''' (no DEA scheduling) (1)

Showing below up to 1 result in range #1 to #1.

V

Viloxazine

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"